Navigation path

FP7 projects

print

Project Acronym Project Title
ATHERO-B-CELL Targeting and exploiting B cell functions for treatment in cardiovascular disease
ATHERO-FLUX Targeting novel lipid pathways for treatment of cardiovascular disease
ATHEROREMO European Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis
BIG-HEART Bench-to-beside Integrated approach to familial hypertrophic cardiomyopathy: to the HEART of the disease
BIOMARCARE Biomarker for Cardiovascular Risk Assessment in Europe
BIOSTAT-CHF A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure
CARDIMMUN A new therapeutic antibody with a personalised medicine approach in cardiovascular disease
CARDIOCELL Development of cardiomyocyte replacement strategy for the clinic
CARDIOGENET Definition of a genetic network involved in congenital heart disease
CARDIOSCAPE A survey of the European cardiovascular research landscape and recommendations for future research strategy
CARTARDIS Identification and validation of novel pharmaceutical drug targets for cardiovascular disease
CHEARTED Gene- Environment Interactions in Heart Development
COUNTERSTROKE Treating stroke with Affibody molecules targeting the inflammatory mediator HMGB1
CULPRIT-SHOCK Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocardial infarction complicated by cardiogenic shock
CVGENES-AT-TARGET Exploitation of genomic variants affecting coronary artery disease and stroke risk for therapeutic intervention
DISCHARGE Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease: Comparative Effectiveness Research of Existing Technologies
DOPPLER-CIP Determining Optimal non-invasive Parameters for the Prediction of Left vEntricular morphologic and functional Remodeling in Chronic Ischemic Patients
EPIC-CVD EPIC-CVD: Individualised CVD risk assessment: tailoring targeted and cost-effective approaches to Europe's diverse populations
EU-CERT-ICD Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope
EU-MASCARA Markers for Sub-Clinical Cardiovascular Risk Assessemnt
EU-PACT A pharmacogenomic approach to coumarin anticoagulant therapy
EUROHYP-1 European multicentre, randomised, phase III clinical trial of hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke
EUSTROKE European Stroke Research Network
EUTRAF The European Network for Translational Research in Atrial Fibrillation
EUTRIGTREAT Identification and therapeutic targeting of common arrhythmia trigger mechanisms
EVINCI-STUDY Evaluation of Integrated Cardiac Imaging for the Detection and Characterization of Ischemic Heart Disease
FAD Fighting Aneurysmal Diseases
FIBRO-TARGETS Targeting cardiac fibrosis for heart failure treatment
INFARCT CELL THERAPY Therapy after heart infarct: prevention of reperfusion injury and repair by stem cell transfer
INHERITANCE INtegrated HEart Research In TrANslational genetics of dilated Cardiomyopathies in Europe
MEDIA The MEtabolic Road to DIAstolic Heart Failure
MITOCARE Treatment of reperfusion injury using a mitochondrial targeted approach: towards a better understanding of the disease.
OPTIMEX Optimizing Exercise Training in Prevention and Treatment of Diastolic Heart Failure
PHASE A PHArmacogenomic study of Statins in the Elderly at risk for cardiovascular disease
PRESTIGE PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort
SHOCKOMICS Multiscale Approach to the Identification of Molecular Biomarkers in Acute Heart Failure Induced By Shock
SICA-HF Studies Investigating Co-morbidities Aggravating Heart Failure
SYSVASC Systems Biology to Identify Molecular Targets for Vascular Disease Treatment
TRANSCARD Translating disease to cardiovascular health
WAKE-UP Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial

Top ^